Literature DB >> 20236090

C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis.

Pierre-Luc Tanguay1, Geneviève Rodier, Sylvain Meloche.   

Abstract

ERK3 (extracellular-signal-regulated kinase 3) is an atypical MAPK (mitogen-activated protein kinase) that is suggested to play a role in cell-cycle progression and cellular differentiation. However, it is not known whether the function of ERK3 is regulated during the cell cycle. In the present paper, we report that ERK3 is stoichiometrically hyperphosphorylated during entry into mitosis and is dephosphorylated at the M-->G1 transition. The phosphorylation of ERK3 is associated with the accumulation of the protein in mitosis. In vitro phosphorylation of a series of ERK3-deletion mutants by mitotic cell extracts revealed that phosphorylation is confined to the unique C-terminal extension of the protein. Using MS analysis, we identified four novel phosphorylation sites, Ser684, Ser688, Thr698 and Ser705, located at the extreme C-terminus of ERK3. All four sites are followed by a proline residue. We have shown that purified cyclin B-Cdk1 (cyclindependent kinase 1) phosphorylates these sites in vitro and demonstrate that Cdk1 acts as a major Thr698 kinase in vivo. Reciprocally, we found that the phosphatases Cdc14A and Cdc14B (Cdc is cell-division cycle) bind to ERK3 and reverse its C-terminal phosphorylation in mitosis. Importantly, alanine substitution of the four C-terminal phosphorylation sites markedly decreased the half-life of ERK3 in mitosis, thereby linking phosphorylation to the stabilization of the kinase. The results of the present study identify a novel regulatory mechanism of ERK3 that operates in a cell-cycle-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236090     DOI: 10.1042/BJ20091604

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway.

Authors:  Paul Déléris; Matthias Trost; Ivan Topisirovic; Pierre-Luc Tanguay; Katherine L B Borden; Pierre Thibault; Sylvain Meloche
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

Review 2.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

3.  Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity.

Authors:  Alina De la Mota-Peynado; Jonathan Chernoff; Alexander Beeser
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

4.  Dynamic regulation of the PR-Set7 histone methyltransferase is required for normal cell cycle progression.

Authors:  Shumin Wu; Weiping Wang; Xiangduo Kong; Lauren M Congdon; Kyoko Yokomori; Marc W Kirschner; Judd C Rice
Journal:  Genes Dev       Date:  2010-10-21       Impact factor: 11.361

5.  Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity.

Authors:  Simon Mathien; Paul Déléris; Mathilde Soulez; Laure Voisin; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2017-04-14       Impact factor: 4.272

6.  Structural and transcriptomic response to antenatal corticosteroids in an Erk3-null mouse model of respiratory distress.

Authors:  Braden K Pew; R Alan Harris; Elena Sbrana; Milenka Cuevas Guaman; Cynthia Shope; Rui Chen; Sylvain Meloche; Kjersti Aagaard
Journal:  Am J Obstet Gynecol       Date:  2016-04-30       Impact factor: 8.661

7.  Tumour promoting and suppressing roles of the atypical MAP kinase signalling pathway ERK3/4-MK5.

Authors:  Sergiy Kostenko; Gianina Dumitriu; Ugo Moens
Journal:  J Mol Signal       Date:  2012-07-16

8.  ERK3 is required for metaphase-anaphase transition in mouse oocyte meiosis.

Authors:  Sen Li; Xiang-Hong Ou; Zhen-Bo Wang; Bo Xiong; Jing-Shan Tong; Liang Wei; Mo Li; Ju Yuan; Ying-Chun Ouyang; Yi Hou; Heide Schatten; Qing-Yuan Sun
Journal:  PLoS One       Date:  2010-09-29       Impact factor: 3.240

9.  Human Cdc14B promotes progression through mitosis by dephosphorylating Cdc25 and regulating Cdk1/cyclin B activity.

Authors:  Indra Tumurbaatar; Onur Cizmecioglu; Ingrid Hoffmann; Ingrid Grummt; Renate Voit
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

10.  G-CSF protects human brain vascular endothelial cells injury induced by high glucose, free fatty acids and hypoxia through MAPK and Akt signaling.

Authors:  Jingjing Su; Houguang Zhou; Yinghong Tao; Jingchun Guo; Zhuangli Guo; Shuo Zhang; Yu Zhang; Yanyan Huang; Yuping Tang; Qiang Dong; Renming Hu
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.